Olmutinib

1353550-13-6

2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-

CHL9B67L95

N-{3-[(2-{[4-(4-Methyl-1-piperazinyl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}acrylamid

N-{3-[(2-{[4-(4-Methyl-1-piperazinyl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}acrylamide

N-{3-[(2-{[4-(4-Méthyl-1-pipérazinyl)phényl]amino}thiéno[3,2-d]pyrimidin-4-yl)oxy]phényl}acrylamide

N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide

Olmutinib

olmutinib

olmutinib

olmutinibum

олмутиниб

ألموتينيب

奥莫替尼

1353550-13-6 (free base)

1802181-20-9

BI 1482694::HM61713::Olmutinib

EGFR_HUMAN

Epidermal growth factor receptor

HM-61713 (BI-1482694)

hm71224, olmutinib

MFCD29918158

N-(3-((2-((4-(4-Methylpiperazin-1-Yl)Phenyl)Amino)Thieno[3,2-D]Pyrimidin-4-Yl)Oxy)Phenyl)Acrylamide

N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide

N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide

olmutinib (hm61713, bi 1482694)

Olmutinib free base

olmutinib(hm-71224)

olmutinib(hm61713,bi1482694)

olmutinibum

олмутиниб

ألموتينيب

奥莫替尼